Background/Aims. Our policy for the surgical treatment of hepatocellular carcinoma (HCC) has been to minimize the extent of liver resection using a microwave tissue coagulator (MTC) and to not perform Pringle's maneuver for the prevention of ischemic injury to the liver routinely. We verify the safety of liver resection using MTC in HCC patients with poor liver functional reserve, and clarify the long-term outcome of HCC patients who underwent curative resection using MTC. Methodology. One hundred sixty-eight patients who underwent curative resection using MTC between 1992 and 2001 were divided into two groups according each patient's score in the Indocyanin Green Retension 15 Test (ICG-R15 test). The high (ICG-R15 values20) and low ICG-R15 groups (ICG-R15 values B20) included 100 and 68 HCC patients, respectively. Clinical characteristics of each group were evaluated, and operative mortality and morbidity, as well as overall and disease-free survival rates, were compared between the two groups to determine risk factors for overall and disease-free survival. Results. Although there were significant differences in liver function-related parameters between the low and high ICG-R15 groups, no differences in surgical or tumor factors were found. No patients in this study developed post-operative liver failure, and there was no significant difference in morbidity between the low and high ICG-R15 groups. The overall survival rate of the low ICG-R15 group was significantly longer than the high ICG-R15 group (p 00.0003). Cox's multivariate analysis showed that an ICG-R15 value less than 20 was the only significant independent factor for overall survival. Disease-free survival rates in the low ICG-R15 group were significantly longer than in the high ICG-R15 group (p 00.0007). Multivariate analysis showed that serum albumin level and number of tumors were significant independent factors for disease-free survival. Conclusion. The long-term outcome of HCC patients with low ICG-R15 following curative resection using MTC was acceptable. This procedure was safe even for patients with high ICG-R15.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world [1] . With the exception of liver transplantation for limited cases [2] and percutaneous local ablative therapy for patients with a solitary and small HCC [3] , liver resection remains the most effective radical approach for HCC treatment. As post-operative mortality and morbidity rates have decreased and long-term outcome has improved, the number of liver resections performed to treat HCC has increased. New techniques have been introduced for safe and effective liver resection. To reduce intra-operative blood loss that correlates with a higher rate of post-operative complication and a shorter survival time, hypotensive anesthetics, Pringle's maneuver [4] , and new devices to transect liver parenchyma [5Á14] have been introduced.
The microwave tissue coagulator (MTC), developed in 1979 by Tabuse [15] , has been applied clinically to the transection of hepatic parenchyma with or without liver cirrhosis. Use of the MTC has been reported to reduce blood loss and to enable nonanatomical liver resections, even in patients with poor liver functional reserve [15Á18] . Our policy for the surgical treatment of HCC has been to minimize the extent of liver resection and to not perform Pringle's maneuver [4] for the prevention of ischemic injury to (Received 10 January 2008; accepted 10 January 2008) the liver routinely. We reported previously that 214 consecutive patients with HCC underwent non-anatomical liver resections using MTC safely with acceptable short-term results and no need for other special techniques [19] . Here we verify the safety of liver resection using MTC in HCC patients with poor liver functional reserve, and clarify the long-term outcome of HCC patients who underwent curative resection using MTC.
Patients and methods
Between April of 1992 and December of 2001, 270 consecutive patients with HCC underwent liver resection in our hepato-pancreatoÁbiliary unit. Of these patients, 214 cases underwent liver resection using a MTC. The remaining 56 cases were excluded from the present analysis for having undergone right/left lobectomy or lateral segmentectomy without using the MTC. Of the 214 patient treated with the MTC, 168 patients who underwent curative resection were divided into two groups according to test values for retension of Indocyanin Green Retension 15 Test (ICG-R15 test). High (ICG-R15 values20) and low (ICG-R15 values520) scoring ICG-R15 groups consisted of 100 and 68 HCC patients, respectively. ''Non-curative resection'' implies that cancer cells or tissues were not removed pathologically by the surgical procedure, or that both liver resection and local ablation therapy were performed simultaneously on multiple tumors in bilateral lobes of the liver. The presence of a tumor thrombus at the IVC, hepatic vein or portal vein also resulted in classification into the ''non-curative resection'' category. Data were collected from the prospective HCC database at Kansai Medical University Hospital. This study was done in accordance with the Helsinki Declaration of 1975.
Perioperative clinical parameters including patient characteristics, preoperative liver function data, operative factors and tumor characteristics were collected (Table 1) . We used the General Rules for the Clinical and Pathological Study of Primary Liver Cancer by the Liver Cancer Study Group of Japan as guidelines for staging [20] . Overall survival rate was calculated and defined as the interval between the date of surgery and the date of death (or the date of last follow-up for living patients). Causes of death included cancer, as well as others such as cerebral bleeding, post-operative bleeding, sepsis, etc. Disease-free survival, defined as the interval between the date of surgery and the date that a diagnosis of recurrence was confirmed by a positive sonogram, computed tomograph, magnetic resonance image or hepatic angiograph, was also evaluated.
All patients were followed monthly, and routine liver biochemical tests were conducted every three months at the central hospital laboratory. Liver ultrasound was performed every three months, and computed tomography and/or magnetic resonance imaging were performed at least every six months. Finally, admitted patients underwent angiographic studies when a recurrence was suspected. Upon confirmation of an intra-hepatic recurrence, patients generally received transarterial chemoembolization (TACE), local ablation therapy, and/or re-resection depending on liver function and on the patient's desire.
Microwave tissue coagulator (MTC)
Basic information and clinical applications of the MTC have been reported in detail by K. Tabuse (a pioneer in the surgical applications of microwave radiation) [21] . This microwave system burns tissue and destroys all tissue structures, including the major blood vessels, within microwave range. The MTC consists of a basic needle applicator and a 2.45 GHz (150W) generator (trade name of Microtaze, Figure 1A ) produced by Alfresa co. Osaka, Japan. The MTC heats liver parenchyma to affect coagulation by internal radiation via a coaxial needle antenna. As shown in Figure 1A , the needle applicator consists of a 10 mm, 15 mm, or 20 mm length electrode and its base. The level of power employed varied from 60 to 80 W, and coagulation and dissociation times were 45 and 15 sec, respectively. To withdraw the needle radiators easily from the coagulated tissue, the Microtaze generator has a dissociation function.
Operative procedure
After laparotomy, tumor location and its relationship to Glisson's sheath and hepatic veins were determined following liver exposition using intraoperative ultrasonography. As shown in Figure 1B -i, and previously in Tabuse et al. [15] and Ryu et al. [16] , liver tissue coagulates during repeated insertion of a monopolar MTC needle electrode along the intended resection line, 2Á3 cm away from the tumor. Coagulated liver tissue was dissected and routinely crushed with forceps without Pringle's procedure ( Figure 1B -ii, iii). Any exposed blood vessels were ligated with sutures.
Statistics
Data were organized using Microsoft TM Excel and are expressed as median (range). Statistical analyzes, including Mann-Whitney U test and Fisher's exact test, were performed using Statview Version 5.0 for Windows (Abacus Concepts, Inc. USA). Kaplan-Meier survival curves were plotted, and log rank tests were performed. For analysis of overall survival and disease-free survival risk factors, univariate or multivariate analysis were performed using Cox's analysis. P values less than 0.05 were considered significant.
Results

Patient backgrounds
Patient, surgical, and tumor characteristics are shown in Table 1 . Among 168 patients, 45% were diagnosed histologically as liver cirrhosis. Hepatitic viruses B and C were found in 73 and 16% of patients, respectively. The median tumor diameter was 3.0 cm, and 78% of patients had only one HCC at surgical resection. Median operative duration and blood loss was 250 min and 902 ml, respectively. Forty-four percent of patients received a blood transfusion. Although there were significant differences in liver functionrelated parameters between low and high ICG-R15 groups, no differences in surgical and tumor factors were found.
Post-operative complications
Post-operative mortality and morbidity rates were 1.8 and 34%, respectively. Three in-hospital deaths occurred in the high ICG-R15 group (two from multiple organ failure due to intra-abdominal bleeding and one from sepsis). No cases of post-operative liver failure developed in this study. Although there was no significant difference in morbidity between the low and high ICG-R15 groups was found, there was a trend toward higher morbidity in the high ICG-R15 group (41% vs. 29%). There were no differences in the frequencies of uncontrollable pleural effusion and ascites, bile leakage, abscess formation, ileus, wound infection or prolonged liver dysfunction between groups.
Overall survival
The overall survival rates for all patients at one, three and five years were 98, 83 and 67%, respectively. There were significant differences in overall survival rates between groups (p00.0003, Figure 2 ): In the low ICG-R15 group, survival rates at one, three, and five years were 98, 88, and 75%, respectively, significantly longer than 97, 76 and 53%, in the high ICG-R15 group. ICG-R15 and serum albumin levels abstracted from the results using Cox's univariate analysis were included in a multivariate analysis identifying ICG-R15 B20% as the only significant independent factor for overall survival ( Table 2) .
Disease-free survival
Disease-free survival rates at one, three and five years for all patients were 83, 47 and 29%, respectively. Disease-free survival rates in the low ICG-R15 group were 84, 58, and 37%, at one, three, and five years, respectively. These values were significantly longer than 81, 31 and 16% at one, three, and five years in the high ICG-R15 group (p 00.0007, Figure 2 ). Cox's univariate analysis showed that the five variables shown in Table II were all independent factors that associated significantly with disease-free survival. Multivariate analysis showed that serum albumin level and number of tumors were independent factors that associated significantly with disease-free survival ( Table 2 ).
Sites of recurrence
By the end of the observation period, 121 patients had tumors reoccur initially in the liver (n 0111, 66%) or extrahepatic sites (n 010, 6%). Tumor recurrence in the liver was solitary in 44 patients (40%) and multiple in 67 patients (60%). Only four patients (2%) showed a recurrent tumor near the cut surface of the liver as well as multiple recurrences by radiological examination. There was no difference in sites of initial recurrence between the low and high Figure 2 . Overall and disease-free survival curves in low-versus high-ICG-R15 group patients Solid and broken lines indicate survival curves in the low and high ICG-R15 groups, respectively. Overall survival rates in the low ICG-R15 group (98, 88 and 75% at one, three and five years, respectively) were significantly longer (p 00.0003) than in the high ICG-R15 group (97, 76 and 53% at one, three, and five years, respectively). Disease-free survival rates in the low ICG-R15 group (84, 58 and 37% at one, three, and five years, respectively) were significantly longer (p 00.0007) than in the high ICG-R15 group (81, 31 and 16%, at one, three, and five years, respectively).
ICG-R15 groups. One hundred and thirteen patients (93%) underwent post-recurrence treatment, whereas eight patients (7%) received no treatment due to poor liver function or patient's wish. Treatments for recurrence among the 113 patients included TACE for 87 (77%), local ablation therapy for 11 (10%), reresection for 12 (11%), and systemic chemotherapy for three (2%). There was no significant difference in treatments for recurrence between the low and high ICG-R15 groups.
Discussion
Although surgical resection represents the best hope for long-term survival in patients with HCC, large amounts of sacrificed non-tumorous liver could restrict surgical indications to avoid post-operative liver failure. Our policy for the surgical treatment of HCC has been to minimize the extent of liver resection and to not perform Pringle's maneuver for the prevention of ischemic injury to the liver routinely. We performed non-anatomical liver resections using MTC in accordance with tumor size. In some cases, liver resections with exposure of the tumor surface at the cut surface of the remnant liver were performed with no surgical margins due to tumor adherence to major hepatic vascular structures or localization to the liver center.
We have reported that no significant differences in overall and disease-free survival rates were found between patients who underwent liver resection with or without surgical margins [22] . Poon et al. [23] suggest that aggressive treatments with multi-modal strategies in HCC patients with intra-hepatic recurrence after curative resection could prolong survival.
In our facility, successful results have been achieved using active hexose-correlated compound (AHCC), a functional food developed by the Amino Up Chemical Co. Ltd (Sapporo, Japan) [24] . Intake of AHCC improved liver function, prevented recurrence of HCC after resection, and prolonged survival of postoperative HCC patients without any adverse effects.
Our previous report demonstrated that liver resection using MTC can be safe and effective [19] . Moreover, common independent prognostic factors for survival and disease-free survival in multivariate analyzes included ICG-R15 score and type of curative resection. In this report, we verify that in HCC patients, the safety and long-term outcome of curative resection using MTC. This study demonstrated that overall and disease-free survival rates in patients with low ICGR15 were significantly better than that in patients with high ICG-R15. There were no significant differences between the two groups in operative time, extent of blood loss or post-operative complications in liver resection using MTC. There were no deaths following post-operative liver failure. Thus, the long-term outcome following curative resection using MTC was acceptable for HCC patients in the low ICG-R15 group, and this type of operation proved safe even for patients in the high ICG-R15 group.
Both surgical curability and post-operative liver functional reserve are generally considered crucial for the successful treatment of patients with HCCs [25Á28]. According to a nationwide survey in Japan in 2003 [29] , 44% of HCC patients treated with surgery had pathologically proven liver cirrhosis and 47% had chronic hepatitis which can result in poor liver reserves. Among the patients in this study, half had pathologically proven liver cirrhosis and 89% were positive for hepatitis virus (17% with type B and 72% with type C hepatitis). Moreover, 40% of the patients in this study with ICG R 15 levels greater than 20% were not considered good candidates for hemi-hepatectomy. Overall patient survival rates in this study were 98, 83 and 67% at one, three, and five years, respectively, which were similar to nation-wide survey results in Japan (92, 74 and 58% at one, three, and five years, respectively) [29] . Progression of liver disease following liver resection can be due not only to tumor recurrence but also to liver decompensation. Because these events represent the main causes of death, the balance between surgical curability and preservation of remnant liver function is of great importance. Although there is a concern of recurrence in the remnant liver, smaller surgical margins could better prevent post-operative complications (including liver failure), particularly in patients with cirrhosis. In the high ICG-R15 group in this study, non-anatomical liver resection using MTC was a safe procedure; however, overall and diseasefree survival were still significantly lower in the high ICG-R15 group than in the low ICG-R15 group. Ercolani et al. have reported that well-compensated cirrhotic patients with a single HCC are good candidates for liver resection, but that they carry a high risk of de novo tumors due to the multifocal carcinogenic potential of cirrhosis [30] . In regard to liver function and surgical curability, liver transplantation is considered the ideal treatment for HCC in cirrhotic patients. However, due to the limited availability of donor organs and consequent delays in transplantation [31] , non-anatomical liver resection using MTC remains a valid surgical option for cirrhotic patients with HCC.
Historically, liver surgeons devised several techniques for safe and effective liver resection: Inflow occlusion of the Pringle maneuver has been used since the early 20th century [4] to prevent intraoperative bleeding during parenchymal transection, which is associated with a higher rate of post-operative complication and a shorter survival time. To control bleeding from the hepatic veins, concomitant use of low central venous pressure (CVP) was then applied [32, 33] . However, because both the Pringle maneuver and low CVP can result in liver damage due to ischemia and reperfusion injury, new devices to transect liver parenchyma, including the suction knife, ultrasonic dissector, YAG laser, water jet, dissecting sealer and MTC, have been introduced [5Á14].
Two randomized controlled trials (RCTs) comparing the traditional clump crushing technique to some of these new devices have been reported. For transection of the liver using the Pringle maneuver, Takayama et al. [5] concluded that ultrasonic dissection offered no reduction in blood loss relative to clamp crushing, and they recommended clamp crushing for liver resection. Recently, Lesurtel et al. [34] reported that relative to Cavitron Ultrasonic Surgical Aspirator (CUSA), hydrojet or dissecting sealers, clamp crushing was the most efficient device in terms of resection time, blood loss and blood transfusion frequency, and also the most cost-efficient device in non-cirrhotic and non-cholestatic patients. Ironically, these RCTs revealed that the efficacy of these expensive devices to transect liver parenchyma was less than or equal to the simple method of clamp crushing. RCT studies comparing microwave surgery to clamp crushing are still needed.
In conclusion, using MTC during curative liver resection in HCC patients with low ICG-R15 values resulted in acceptable long-term outcomes. This type of operation was also safe procedure for patients with high ICG-R15. Although liver transplantation remains the ideal treatment for HCC in cirrhotic patients with regard to liver function and surgical curability, the present situation of limited donor organ availability and transplantation delay promotes nonanatomical liver resection using MTC as an immediate and viable surgical option for cirrhotic patients with HCC.
